FDFT1 and hepatocellular carcinoma: Further, it has been shown that rat and human hepatocellular carcinoma cells display increased mitochondrial cholesterol levels and HMGCR or squalene synthase (FDFT1) inhibition sensitizes those cells to mitochondria-directed chemotherapy [15].